Standardized approaches to the treatment of neonatal seizures remain undeveloped. We
assessed the type and number of anticonvulsants selected, blood levels attained, and …

Neonatal seizures are one of the most common neurological disorders in infants. However,
the optimal treatment strategy for neonatal seizures remains controversial and there is little …

There is a pressing need for consistent, evidence-based guidelines in the management of
neonatal seizures by pediatric neurologists and neonatologists. Israeli pediatric neurologists …

There is a lack of scientific evidence to support the best management of neonatal seizures.
Current strategies for neonatal seizure management were investigated by analysis of all …

Medically refractory neonatal seizures represent a major therapeutic challenge in neonatal
intensive care units. Conventional antiepileptic drugs demonstrate limited efficacy. Previous …

Seizures are the most common neurological emergencies in the neonatal period and are
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …

Pharmacologic treatment options for neonatal seizures have expanded over the past 2
decades, and there is no consensus on optimal treatment strategy. We systematically …

In childhood, the risk of seizures is highest in the neonatal period (1.8 to 3.5/1000 live births
in the United States). Neonatal seizures (NS) are associated with high mortality and …

Seizures occur more often during the neonatal period than at any other period of life. Precise
incidence is difficult to delineate and depends on study population and criteria used for …

Objective Seizures are a common neonatal neurologic emergency. Many centers have
developed pathways to optimize management. We evaluated neonatal seizure management …